‘Help is on the way’
Translation and Interpreting Studies · 31.12.2022 · 17 (3) · 455-477
DOI: 10.1075/tis.21040.ski ↗Kurz gefasst
Fachartikel in der Zeitschrift Translation and Interpreting Studies, online erschienen am 22.05.2023. Verfasst von Robert Skinner und 1 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Commission.
Abstract (Originalsprache)
In the UK, police reforms to meet needs of a diverse society have been limited in the case of deaf signers to an increase in sign language interpreting services (SLIS). This article explores the consequences of this dependence on SLIS by the UK police. We consider how deaf signers’ contact with the police may be inaccessible, despite national frameworks that ‘guarantee’ accessibility through the provision of BSL-English interpreting. We draw on qualitative data from focus groups and interviews with police officers and custody sergeants who describe their experiences of having contact with deaf signers (or other minority language users) through interpreters. We examine and contrast their perceptions and experiences concerning if, when, and how SLIS provided access, as well as its impact on their contact with deaf signers. We compare these findings with UK police reform policies to identify the current state of these provisions along with potential divergences.
Förderung
- European Commission
Zitieren
APA
Skinner, R., & Napier, J. (2022). ‘Help is on the way’. Translation and Interpreting Studies, 17(3), 455-477. https://doi.org/10.1075/tis.21040.ski
Vancouver
Skinner R, Napier J. ‘Help is on the way’. Translation and Interpreting Studies. 2022;17(3):455-477. doi:10.1075/tis.21040.ski
BibTeX
@article{Skinner2022,
author = {Skinner, Robert and Napier, Jemina},
title = {‘Help is on the way’},
journal = {Translation and Interpreting Studies},
year = {2022},
volume = {17},
number = {3},
pages = {455--477},
doi = {10.1075/tis.21040.ski}
}
EUVIMED